OmniaManufacturing Services for Novel Biologics

Cells
About the images

Company Profile

Omnia offers an array of manufacturing and process development services for companies engaged in the development of novel biologics. Our experience in many of these areas – from preclinical gene therapeutics through commercial recombinant proteins – gives Omnia a unique and specialized approach for developing manufacturing processes.

The company has both non-GMP and GMP facilities for process development through Phase I/II manufacture.


Technical Focus: 
- Adenovirus
- Lentivirus
- Retrovirus
- AAV
- VLP
- Other viral platforms 

Contact us to meet at our scheduled
conferences and tradeshows:
- Biopharmaceutical Development and Production Week - IBC
  Life Sciences (San Diego, CA, February 27 - March 2, 2012)
- ISBioTech Annual Meeting (Rosslyn, VA, April 2-4, 2012)
- World Vaccine Congress (Washington, DC, April 10-13, 2012)
- FAES NIH CRM Stem Cell Industry Symposium (Bethesda,
  MD, May 11, 2012)
- ASGCT (Philadelphia, PA, May 15-19, 2012)
- BIO International Convention (Boston, MA, June 18-21, 2012)
- 6th Vaccine and ISV Congress (Shanghai, China, October 14-
  16, 2012)